OPTImisation and Standardization of CIRCulating Cell-free DNA Ex-traction Protocols in a Diagnostic Setting
Launched by UNIVERSITY HOSPITAL TUEBINGEN · Mar 6, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to find the best way to collect and prepare blood samples for testing a special type of DNA found in the blood called cell-free DNA (cfDNA). Researchers want to compare different blood collection tubes and extraction methods to see which combination provides the highest quality and quantity of cfDNA. This information is important for future tests that help diagnose health conditions using advanced DNA analysis techniques.
To participate in this study, you need to be at least 18 years old and generally healthy, meaning you should not have any serious health conditions that could affect the amount of cfDNA in your blood. If you qualify and decide to join, you will be asked to provide a blood sample, which will be used to help improve the accuracy of future medical tests. The trial is not yet recruiting participants, but it aims to enhance the way we understand and analyze DNA in a clinical setting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at least 18 years
- • no serious condition
- Exclusion Criteria:
- • younger than 18 years
- • serious health condition that leads to higher cfDNA content in blood
About University Hospital Tuebingen
University Hospital Tübingen is a leading academic medical institution in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its multidisciplinary expertise and cutting-edge facilities to develop new therapeutic strategies and improve patient outcomes. With a strong focus on translational medicine, University Hospital Tübingen collaborates with various stakeholders, including pharmaceutical companies and research organizations, to facilitate the efficient and ethical conduct of trials across a wide range of medical disciplines. Their dedication to patient-centered research and rigorous scientific standards positions them at the forefront of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported